These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 11922493)
1. Rectal administration of misoprostol for the management of retained placenta--a preliminary report. Li YT; Yin CS; Chen FM Zhonghua Yi Xue Za Zhi (Taipei); 2001 Dec; 64(12):721-4. PubMed ID: 11922493 [TBL] [Abstract][Full Text] [Related]
2. Prostaglandins for management of retained placenta. Grillo-Ardila CF; Ruiz-Parra AI; Gaitán HG; Rodriguez-Malagon N Cochrane Database Syst Rev; 2014 May; 2014(5):CD010312. PubMed ID: 24833288 [TBL] [Abstract][Full Text] [Related]
3. Rectal misoprostol in management of retained placenta: a contradictory result. Pongsatha S; Tongsong T J Med Assoc Thai; 2011 May; 94(5):535-9. PubMed ID: 21675440 [TBL] [Abstract][Full Text] [Related]
4. Rectal misoprostol vs 15-methyl prostaglandin F2alpha for retained placenta after second-trimester delivery. Sundaram S; Diaz JP; González-Quintero VH; Verma U Am J Obstet Gynecol; 2009 May; 200(5):e24-6. PubMed ID: 19136084 [TBL] [Abstract][Full Text] [Related]
5. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol. Ashok PW; Flett GM; Templeton A Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062 [TBL] [Abstract][Full Text] [Related]
6. Intervention rates for placental removal following induction abortion with misoprostol. Green J; Borgatta L; Sia M; Kapp N; Saia K; Carr-Ellis S; Vragovic O Contraception; 2007 Oct; 76(4):310-3. PubMed ID: 17900443 [TBL] [Abstract][Full Text] [Related]
7. No reduction of manual removal after misoprostol for retained placenta: a double-blind, randomized trial. van Stralen G; Veenhof M; Holleboom C; van Roosmalen J Acta Obstet Gynecol Scand; 2013 Apr; 92(4):398-403. PubMed ID: 23231499 [TBL] [Abstract][Full Text] [Related]
8. Intraumbilical injection of three different uterotonics in the management of retained placenta. Harara R; Hanafy S; Zidan MS; Alberry M J Obstet Gynaecol Res; 2011 Sep; 37(9):1203-7. PubMed ID: 21518127 [TBL] [Abstract][Full Text] [Related]
9. The association between history of retained placenta and success rate of misoprostol treatment for early pregnancy failure. Cohen A; Gutman-Ido E; Karavani G; Albeck A; Rosenbloom JI; Shushan A; Chill HH BMC Womens Health; 2023 Oct; 23(1):523. PubMed ID: 37794425 [TBL] [Abstract][Full Text] [Related]
10. A medical approach to management of spontaneous abortion using misoprostol. Extending misoprostol treatment to a maximum of 48 hours can further improve evacuation of retained products of conception in spontaneous abortion. Chung T; Leung P; Cheung LP; Haines C; Chang AM Acta Obstet Gynecol Scand; 1997 Mar; 76(3):248-51. PubMed ID: 9093140 [TBL] [Abstract][Full Text] [Related]
11. Placental retention in late first and second trimester pregnancy termination using misoprostol: a retrospective analysis. van der Knoop BJ; Vandenberghe G; Bolte AC; Go AT J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1287-91. PubMed ID: 21999155 [TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial on the value of misoprostol for the treatment of retained placenta in a low-resource setting. van Beekhuizen HJ; Tarimo V; Pembe AB; Fauteck H; Lotgering FK Int J Gynaecol Obstet; 2013 Sep; 122(3):234-7. PubMed ID: 23791153 [TBL] [Abstract][Full Text] [Related]
13. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study]. Verhulsdonk MT; Papatsonis DN; Heydanus R Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323 [TBL] [Abstract][Full Text] [Related]
14. Experience with intravaginal misoprostol in the management of intra-uterine fetal death. Fawole AO; Adekunle AO; Sotiloye OS; Arowojolu AO; Otolorin EO Afr J Med Med Sci; 2004 Jun; 33(2):105-8. PubMed ID: 15565925 [TBL] [Abstract][Full Text] [Related]
15. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction. Ramsey PS; Savage K; Lincoln T; Owen J Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013 [TBL] [Abstract][Full Text] [Related]
16. Umbilical vein injection of misoprostol versus normal saline for the treatment of retained placenta: intrapartum placebo-controlled trial. Rajab SS; Alalaf SK BMC Pregnancy Childbirth; 2014 Jan; 14():37. PubMed ID: 24444360 [TBL] [Abstract][Full Text] [Related]
17. Sulprostone reduces the need for manual removal of the placenta in patients with retained placenta: a randomized controlled trial. Radhakrishnan G; Singh G Am J Obstet Gynecol; 2007 Mar; 196(3):e13; author reply e13-4. PubMed ID: 17346503 [No Abstract] [Full Text] [Related]
18. Misoprostol: a quarter century of use, abuse, and creative misuse. Chong YS; Su LL; Arulkumaran S Obstet Gynecol Surv; 2004 Feb; 59(2):128-40. PubMed ID: 14752301 [TBL] [Abstract][Full Text] [Related]
19. Umbilical vein oxytocin in the management of retained placenta: an alternative to manual removal of placenta? Lim PS; Singh S; Lee A; Muhammad Yassin MA Arch Gynecol Obstet; 2011 Nov; 284(5):1073-9. PubMed ID: 21136267 [TBL] [Abstract][Full Text] [Related]
20. A comparison of the efficacy of sublingual and oral misoprostol 400 microgram in the management of early pregnancy failure: a randomized controlled trial. Ayudhaya OP; Herabutya Y; Chanrachakul B; Ayuthaya NI; O-Prasertsawat P J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S5-10. PubMed ID: 17726806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]